Lack of MEF2A mutations in coronary artery disease

Journal of Clinical Investigation

Volumn 115, Issue 4, 2005, Pages 1016-1020

  Weng, Li ^a   Kavaslar, Nihan ^b   Ustaszewska, Anna ^a   Doelle, Heather ^b   Schackwitz, Wendy ^a   Hébert, Sybil ^b   Cohen, Jonathan C ^c   McPherson, Ruth ^b   Pennacchio, Len A ^a,d  

^a U S DEPARTMENT OF ENERGY   (United States)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEF2A GENE; PRIORITY JOURNAL; RNA SPLICING; SCREENING;

EID: 16844368100     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI24186     Document Type: Article

References (29)

1. Yusuf, S., Reddy, S., Ounpuu, S., and Anand, S. 2001. Global burden of cardiovascular diseases. I. General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 104:2746-2753.
2. Schildkraut, J.M., Myers, R.H., Cupples, L.A., Kiely, O.K., and Kannel, W.B. 1989. Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am. J. Cardiol. 64:555-559.
3. Greenland, P., et al. 2003. Major risk factors as antecedents of fatal and nonfaral coronary heart disease events. JAMA. 290:891-897.
4. Lusis, A.J. 2000. Atherosclerosis. Nature. 407:233-241.
5. Nora, J.J., Lortscher, R.H., Spangler, R.D., Nora, A.N., and Kimberling, W.J. 1980. Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation. 61:503-508.
6. Broeckel, U., et al. 2002. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat. Genet. 30:210-214.
7. Harrap, S.B., et al. 2002. Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler. Thromb. Vasc. Biol. 22:874-878.
8. Francke, S., et al. 2001. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum.Mol. Genet. 10:2751-2765.
9. Chen, Q., et al. 2003. Genetic variation in lectin-like oxidized low-density Hpoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Circulation. 107:3146-3151.
10. Wang, Q., et al. 2004. Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am. J. Hum. Genet. 74:262-271.
11. Topol, E.J., et al. 2001. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation. 104:2641-2644.
12. Pajukanta, P., et al. 2000. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am. J. Hum. Genet. 67:1481-1493.
13. Hauser, E.R., et al. 2004. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am. J. Hum. Genet. 75:436-447.
14. Lusis, A.J. 2003. Genetic factors in cardiovascular disease. 10 questions. Trends Cardiovasc. Med. 13:309-316.
15. Scheuner, M.T. 2003. Genetic evaluation for coronary artery disease. Genet. Med. 5:269-285.
16. Wang, L., Fan, C., Topol, S.E., Topol, E.J., and Wang, Q. 2003. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science. 302:1578-1581.
17. McKinsey, T.A., Zhang, C.L., and Olson, E.N. 2002. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 27:40-47.
18. Black, B.L., and Olson, E.N. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:167-196.
19. Naya, F.J., et al. 2002. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat. Med. 8:1303-1309.
20. Bhagavatula, M.R.K., et al. 2004. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum. Mol. Genet. 13:3181-3188.
21. European Molecular Biology Laboratory. 2004. PolyPhen: prediction of functional effect of human nonsynonymous SNPs. http://www.bork.embl-heidelberg. de/PolyPhen/.
22. Sunyaev, S., et al. 2001. Prediction of deleterious human alleles. Hum. Mol. Genet. 10:591-597.
23. Ramensky, V., Bork, P., and Sunyaev, S. 2002. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30:3894-3900.
24. Miller, S.A., Dykes, D.D., and Polesky, H.F. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
25. ELXR: exon resequencing primer design tool. http://mutation.swmed.edu/ex- lax.
26. Lansang, C., et al. 2004. Post-Sequencing BET Cleanup Protocol. http://www.jgi.doe.gov/sequencing/protocols/AutomatedBETCleanup-SOP.doc.
27. Khan, A., and Jett, J. 2004. Cycle sequencing using BigDye v3.1: performed on fosmid DNA template. http://www.jgi.doe.gov/sequencing/protocols/ BigDyev3.1FosmidCycleSequencingSOP.doc.
28. Green, P. 2004. Phred, Phrap, Consed sequence analysis tools. http://www.phrap.org/phred-phrapconsed.html.
29. Nickerson Group. 2003. PolyPhred. http://droog.mbt.washington.edu/ PolyPhred.html.